MDRX (Veradigm) Issuance of Debt: $21.6 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDRX Veradigm Inc MDRX
23 GF Score
Price $4.90
View Full Analysis

What is Veradigm Issuance of Debt?

Veradigm MDRX +1.87% 23 Issuance of Debt is $21.6 Mil as of Dec. 2022. GuruFocus rates MDRX with a GF Score™ of 23/100.

Veradigm's Issuance of Debt for the six months ended in Dec. 2022 was $21.6 Mil.

Veradigm's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2022 was $21.6 Mil.

Veradigm Issuance of Debt Related Terms

Veradigm Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Veradigm's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradigm Issuance of Debt Chart

Veradigm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 497.24 2,218.63 325.00 21.64 0.00

Veradigm Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 May09 May10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 497.24 2,218.63 325.00 21.64 0.00
MDRX
23GF Score
Veradigm Inc MDRX
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veradigm Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2022 was $21.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $21.6 Mil mean?
Veradigm (MDRX) has a Issuance of Debt of $21.6 Mil as of Dec. 2022. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Veradigm and its competitors.
Is Veradigm's Issuance of Debt too high?
Veradigm's current Issuance of Debt is $21.6 Mil. Overall, Veradigm has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Issuance of Debt compare to WEAV and PHR?
Veradigm's Issuance of Debt of $21.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Healthcare Providers & Services company?
A good Issuance of Debt depends on the Healthcare Providers & Services industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Veradigm and its competitors. Veradigm's current Issuance of Debt is $21.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (MDRX) has a current Issuance of Debt of $21.6 Mil. The current Issuance of Debt is $21.6 Mil. Veradigm's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Veradigm (MDRX), the current Issuance of Debt is $21.6 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradigm Business Description

Address 222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
23GF Score

Get the complete analysis for MDRX

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.90
Price